Advertisement
Screener

PROPANC BIOPHARMA, INC. (PPCB) Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount

0.6 / 5 stars · 6/48 Roast Me

PROPANC BIOPHARMA, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount

PROPANC BIOPHARMA, INC. (PPCB) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount of $179.31 thousand for the 12-month period ending 2018-06-30, per its 10-K filed 2018-09-17.

Discontinued › Expense Statement › Income Tax

us-gaap:IncomeTaxReconciliationTaxCreditsResearch · last filed 2018-09-17

  • PROPANC BIOPHARMA, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2018 was $179.31K, a 41.34% decline from fiscal 2017.
  • PROPANC BIOPHARMA, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2017 was $305.67K, a 321.40% increase from fiscal 2016.
  • PROPANC BIOPHARMA, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2016 was $72.54K, a 6.37% decline from fiscal 2015.
  • PROPANC BIOPHARMA, INC. effective income tax rate reconciliation, tax credit, research, amount for fiscal 2015 was $77.47K.
Period endEffective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month
2018-06-30$179.31K
10-K · filed 2018-09-17
2017-06-30$305.67K
10-K · filed 2018-09-17
2016-06-30$72.54K
10-K · filed 2017-09-28
2015-06-30$77.47K
10-K · filed 2016-09-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
NANOVIRICIDES, INC. (NNVC)United States$0.031B
BeyondSpring Inc. (BYSI)United States$0.031B-10.95
Context Therapeutics Inc. (CNTX)United States$0.034B-1.10
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45